Assessment of a superparamagnetic iron oxide (ami‐25) as a brain contrast agent
- 1 March 1990
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 13 (3) , 434-443
- https://doi.org/10.1002/mrm.1910130310
Abstract
We have applied a superparamagnetic iron oxide formulation (AMI-25, Advanced Magnetics, Inc., Cambridge, MA) to image the cerebral vasculature. Contrast-enhanced images of normal anesthetized rats demonstrated excellent gray/white matter differentiation, consistent with known differences in blood perfusion, and cerebrospinal fluid spaces were clearly seen. Alterations in normal perfusion patterns due to barbiturate anesthesia and ischemia were clearly visible. We propose the use of this agent as an adjunct to MRI for the imaging of conditions with perfusion abnormalities. © 1990 Academic Press, Inc.This publication has 8 references indexed in Scilit:
- CEREBRAL BLOOD-VOLUME IN A RAT MODEL OF ISCHEMIA BY MR IMAGING AT 4.7-T1989
- FERRITE PARTICLES - A NEW MAGNETIC-RESONANCE-IMAGING CONTRAST AGENT - LACK OF ACUTE OR CHRONIC HEPATOTOXICITY AFTER INTRAVENOUS ADMINISTRATION1987
- Three-Dimensional Representation and Analysis of Brain Energy MetabolismScience, 1987
- Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.Radiology, 1987
- Ferromagnetic contrast agents: A new approachMagnetic Resonance in Medicine, 1986
- A modified method for the simultaneous determination of regional single-transit brain extraction of diffusion-limited compounds and cerebral blood flow: Utilization of non-invasive measurement of transit timeBrain Research, 1985
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982
- Insulin effects on monovalent cation transport and Na-K-ATPase activityAmerican Journal of Physiology-Cell Physiology, 1978